Who Is Young America Capital and Why Should You Care

Young America Capital LLC is not a bank that millions of ordinary people use. It is a boutique investment banking firm. But the rules it ignored exist precisely because investment banks are a documented pipeline for financial crime.

• Young America Capital has been a FINRA-registered broker-dealer since March 2010, operating out of Mamaroneck, New York, with approximately 50 registered representatives and one branch office.
• The firm’s primary business is investment banking and mergers and acquisitions advisory services. It specifically serves clients in cannabis, life sciences, and technology, media, and telecommunications sectors: industries regulators have flagged as elevated money laundering risks.
• Most of the firm’s revenue since at least 2020 came from private placement advisory fees. Private placements are deals that are not publicly traded and face far less automatic scrutiny than publicly listed securities, making them attractive vehicles for moving dirty money.
• The Bank Secrecy Act and its implementing regulations require all broker-dealers, including investment banks, to file Suspicious Activity Reports (SARs) with the Financial Crimes Enforcement Network (FinCEN) whenever a transaction looks like it could involve money laundering or other financial crime. Young America’s position was, in effect, that those rules did not apply to them.

The Non-Financial Ledger: What Rules Like This Are Actually For

Anti-money laundering rules are not paperwork bureaucracy. They are the mechanism society built to make financial crime expensive and traceable. When a firm deliberately writes itself an exemption from those rules, it is not making an administrative error. It is choosing a side.

The Bank Secrecy Act exists because drug cartels, human traffickers, corrupt officials, and fraudsters need somewhere to park and clean their money. They need financial professionals who will process transactions without asking questions. Suspicious Activity Reports exist specifically to make that harder. When Young America Capital wrote into its own compliance manual that it had “no obligation to monitor for or report suspicious activity,” it was building a wall between its own employees and the legal duty to ask those questions.

Think about what that means in practice. The firm worked with cannabis companies, a sector where, as of FinCEN’s 2014 guidance, the rules around SAR filings are specific and detailed. Cannabis remains federally illegal. The money flowing through cannabis-adjacent investment deals carries a documented risk of intermingling with criminal proceeds. Young America’s registered representatives, about 50 people, were given training that contained zero mention of cannabis-related financial crime risks. They were handed a playbook designed for a completely different type of business and told: this is what to watch for.

By the time FINRA issued its settlement in February 2025, Young America had received four separate external signals that its AML program was defective: an SEC warning in 2020, a FINRA examination exception in 2022, an independent testing recommendation in 2022, and another independent testing flag in July 2023. At each of those moments, the firm had a choice. At each of those moments, it chose not to fix the problem. The cannabis guidance that briefly appeared in 2022 was not just left incomplete; it was actively removed later that same year.

The people who pay the price for this kind of institutional negligence are rarely visible. They are the communities where money laundering flourishes because financial gatekeepers looked away. They are the workers and small investors displaced by fraudulent capital flows in the industries this firm advised. They are the regulators whose ability to trace financial crime depends on a chain of reporting that breaks whenever a firm like Young America decides the rules are for someone else. And they are the 50 registered representatives who were set up to fail, working without the tools or knowledge to recognize crime when they saw it.

“They were given training designed for a business they don’t run, about risks they were never taught to see, in an industry they were actively serving.”

Legal Receipts: What the Documents Actually Say

These are verbatim from FINRA AWC No. 2021069389701, accepted February 26, 2025. No paraphrasing.

Societal Impact: Who Gets Hurt When Gatekeepers Step Aside

Public Health

The Bank Secrecy Act’s SAR reporting requirement is a public health tool as much as a financial one. It exists to disrupt the financial infrastructure of drug trafficking, human trafficking, and fraud. When investment firms serving cannabis-adjacent sectors operate without functional AML monitoring, the chain of financial oversight breaks.

• FinCEN’s 2014 guidance specifically addressed cannabis-related businesses because illicit cannabis proceeds and legal cannabis revenue can flow through the same financial channels. Without SAR monitoring, transactions that should trigger law enforcement review pass through undetected, including potential co-mingling of cartel-linked proceeds with legitimate investment activity.
• Young America’s 50 registered representatives served numerous issuers and companies in the cannabis sector from at least 2020 through at least 2025, a five-year span during which the firm conducted zero documented review of those transactions for suspicious activity patterns.
• Money laundering through investment banking deals has been documented as a financing mechanism for organized crime, which funds violence and drug distribution networks in the communities where that cash ultimately circulates. Firms that refuse to serve as watchdogs remove a layer of detection that federal law specifically placed at their level.

Economic Inequality

Private placement markets, where Young America primarily operates, are structurally inaccessible to ordinary people. They are also structurally less transparent. When the firms that intermediate these markets do not monitor for fraud or laundering, the asymmetry of risk falls hardest on the parties with the least power.

• Fraudulent or criminally backed capital entering private placement deals can distort valuations, crowd out legitimate capital, and ultimately harm the businesses and employees who depend on honest investment. Workers at cannabis or life sciences companies funded through deals Young America structured had no way to know whether the money backing their employer had been properly screened.
• The $50,000 fine levied against Young America amounts to a rounding error for a firm whose primary revenue source was investment banking advisory fees across multiple high-value M&A and private placement deals over several years. There is no disclosed clawback of fees earned during the period of non-compliance. The firm profits from the period in which its AML program was broken, and pays a fine that does not come close to the revenue generated in that window.
• FINRA’s finding that the firm “violated FINRA Rules 3310(a), 3310(e), 3310(f)(ii) and 2010” represents the minimum floor of accountability. FINRA Rule 2010 requires “high standards of commercial honor and just and equitable principles of trade.” The firm’s conduct during the documented period fails that standard by design, not by accident.
• Smaller firms that do invest in proper AML infrastructure bear a compliance cost. Firms like Young America, which skip that investment, gain a competitive cost advantage funded by disregarding the law. That economic structure rewards non-compliance and penalizes firms that play by the rules.

The “Cost of a Life” Metric

FINRA imposed a $50,000 fine for at least four years of documented AML failure across a firm serving high-risk cannabis, life sciences, and tech sectors with approximately 50 registered representatives.

The firm also agreed to a censure and an undertaking requiring a senior management certification of remediation within 60 days. No disgorgement of advisory fees earned during the non-compliance period was ordered. No individual officers or principals were sanctioned. The $50,000 fine is the entirety of the monetary consequence for the documented conduct.

What Now: Who to Contact and What to Demand

Young America Capital’s senior management, holding the title of CEO per the signature block of the AWC, must certify remediation to FINRA within 60 days of notice of acceptance. That certification must include a narrative description and supporting exhibits. Here is what accountability looks like at every level.

• Young America Capital LLC (CRD No. 150443, Mamaroneck, New York): The firm is required to submit written certification of remediation. Its WSPs must now contain red flags actually tailored to investment banking and M&A advisory work, including cannabis-specific SAR guidance. Verify this on FINRA BrokerCheck at finra.org/brokercheck.
• FINRA Enforcement Contact: Rebecca Kinburn, Counsel, FINRA Department of Enforcement, 581 Main Street, Suite 710, Woodbridge, NJ 07095; rebecca.kinburn@finra.org; copy to EnforcementNotice@finra.org. This contact is public record per the AWC.
• The AWC is now part of Young America Capital’s permanent disciplinary record and is publicly accessible through FINRA’s disclosure program under Rule 8313.

• FINRA (Financial Industry Regulatory Authority): The primary regulator for broker-dealers. Filed this action. Monitor Young America Capital’s BrokerCheck profile for certification status and any future actions.
• FinCEN (Financial Crimes Enforcement Network): The U.S. Treasury bureau that receives SAR filings. Issued the 2014 cannabis guidance the firm ignored. If you believe suspicious transactions went unreported, FinCEN accepts tips at fincen.gov.
• SEC (Securities and Exchange Commission): Already warned Young America in 2020. The SEC’s whistleblower program (sec.gov/whistleblower) accepts tips about broker-dealer non-compliance and pays awards for information leading to sanctions over $1 million.
• DOJ (Department of Justice) / Financial Crimes Unit: If the broken AML program allowed actual money laundering to proceed undetected, transactions from the non-compliance period may warrant criminal review. DOJ’s money laundering tip line: justice.gov/criminal-afmls.

• If you work in financial services: Know that FINRA’s whistleblower and tip processes are available to industry insiders. If you see a firm operating with compliance theater rather than real AML programs, you have both the legal standing and the moral obligation to report it. Use FINRA’s online tip system at finra.org/investors/have-problem/file-complaint.
• Demand proportionate fines: A $50,000 fine for four-plus years of systemic non-compliance at an investment bank is a known structural problem in financial regulation. Contact your Congressional representatives and demand that FINRA and the SEC be authorized and directed to impose fines scaled to firm revenue, not flat caps that function as cost-of-doing-business line items.
• Support investigative journalism: Cases like this appear in public records because regulators publish enforcement actions. Organizations that index, analyze, and report on those documents provide the only public-facing accountability layer that exists for conduct like this. Fund them directly.
• Check your own investment exposure: If you have any stake in private placement deals, cannabis-sector investments, or M&A transactions that passed through smaller FINRA-registered broker-dealers, verify the AML standing of those firms on BrokerCheck. A disciplinary record is a signal, not a verdict, but it is public and free to access.